1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Penicillin G Acylase Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Penicillin G Acylase Market Revenue and Volume, by Type
8.1.1. Free Enzyme
8.1.1.1. Market Revenue and Volume Forecast
8.1.2. Immobilized Enzyme
8.1.2.1. Market Revenue and Volume Forecast
8.1.3. Others: Enzyme blends, recombinant PGA
8.1.3.1. Market Revenue and Volume Forecast
9.1. Penicillin G Acylase Market Revenue and Volume, by Application
9.1.1. β-Lactam Antibiotic Production
9.1.1.1. Market Revenue and Volume Forecast
9.1.2. Cephalosporin Derivatives
9.1.2.1. Market Revenue and Volume Forecast
9.1.3. Industrial Biocatalysis
9.1.3.1. Market Revenue and Volume Forecast
9.1.4. Research & Development
9.1.4.1. Market Revenue and Volume Forecast
9.1.5. Others: Specialty chemicals, biosensor applications
9.1.5.1. Market Revenue and Volume Forecast
10.1. Penicillin G Acylase Market Revenue and Volume, by End-Use Industry
10.1.1. Pharmaceutical Industry
10.1.1.1. Market Revenue and Volume Forecast
10.1.2. Biotechnology Companies
10.1.2.1. Market Revenue and Volume Forecast
10.1.3. Contract Manufacturing Organizations (CMOs)
10.1.3.1. Market Revenue and Volume Forecast
10.1.4. Research Institutes & Academic Labs
10.1.4.1. Market Revenue and Volume Forecast
10.1.5. Others: Specialty chemical manufacturers
10.1.5.1. Market Revenue and Volume Forecast
11.1. Penicillin G Acylase Market Revenue and Volume, by Form
11.1.1. Powder
11.1.1.1. Market Revenue and Volume Forecast
11.1.2. Liquid
11.1.2.1. Market Revenue and Volume Forecast
11.1.3. Others: Lyophilized formulations
11.1.3.1. Market Revenue and Volume Forecast
12.1. Penicillin G Acylase Market Revenue and Volume, by Production Method
12.1.1. Microbial Fermentation
12.1.1.1. Market Revenue and Volume Forecast
12.1.2. Recombinant Technology
12.1.2.1. Market Revenue and Volume Forecast
12.1.3. Others: Enzyme immobilization techniques
12.1.3.1. Market Revenue and Volume Forecast
13.1. North America
13.1.1. Market Revenue and Volume Forecast, by Type
13.1.2. Market Revenue and Volume Forecast, by Application
13.1.3. Market Revenue and Volume Forecast, by End-Use Industry
13.1.4. Market Revenue and Volume Forecast, by Form
13.1.5. Market Revenue and Volume Forecast, by Production Method
13.1.6. U.S.
13.1.6.1. Market Revenue and Volume Forecast, by Type
13.1.6.2. Market Revenue and Volume Forecast, by Application
13.1.6.3. Market Revenue and Volume Forecast, by End-Use Industry
13.1.6.4. Market Revenue and Volume Forecast, by Form
13.1.6.5. Market Revenue and Volume Forecast, by Production Method
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Volume Forecast, by Type
13.1.7.2. Market Revenue and Volume Forecast, by Application
13.1.7.3. Market Revenue and Volume Forecast, by End-Use Industry
13.1.7.4. Market Revenue and Volume Forecast, by Form
13.1.7.5. Market Revenue and Volume Forecast, by Production Method
13.2. Europe
13.2.1. Market Revenue and Volume Forecast, by Type
13.2.2. Market Revenue and Volume Forecast, by Application
13.2.3. Market Revenue and Volume Forecast, by End-Use Industry
13.2.4. Market Revenue and Volume Forecast, by Form
13.2.5. Market Revenue and Volume Forecast, by Production Method
13.2.6. UK
13.2.6.1. Market Revenue and Volume Forecast, by Type
13.2.6.2. Market Revenue and Volume Forecast, by Application
13.2.6.3. Market Revenue and Volume Forecast, by End-Use Industry
13.2.7. Market Revenue and Volume Forecast, by Form
13.2.8. Market Revenue and Volume Forecast, by Production Method
13.2.9. Germany
13.2.9.1. Market Revenue and Volume Forecast, by Type
13.2.9.2. Market Revenue and Volume Forecast, by Application
13.2.9.3. Market Revenue and Volume Forecast, by End-Use Industry
13.2.10. Market Revenue and Volume Forecast, by Form
13.2.11. Market Revenue and Volume Forecast, by Production Method
13.2.12. France
13.2.12.1. Market Revenue and Volume Forecast, by Type
13.2.12.2. Market Revenue and Volume Forecast, by Application
13.2.12.3. Market Revenue and Volume Forecast, by End-Use Industry
13.2.12.4. Market Revenue and Volume Forecast, by Form
13.2.13. Market Revenue and Volume Forecast, by Production Method
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Volume Forecast, by Type
13.2.14.2. Market Revenue and Volume Forecast, by Application
13.2.14.3. Market Revenue and Volume Forecast, by End-Use Industry
13.2.14.4. Market Revenue and Volume Forecast, by Form
13.2.15. Market Revenue and Volume Forecast, by Production Method
13.3. APAC
13.3.1. Market Revenue and Volume Forecast, by Type
13.3.2. Market Revenue and Volume Forecast, by Application
13.3.3. Market Revenue and Volume Forecast, by End-Use Industry
13.3.4. Market Revenue and Volume Forecast, by Form
13.3.5. Market Revenue and Volume Forecast, by Production Method
13.3.6. India
13.3.6.1. Market Revenue and Volume Forecast, by Type
13.3.6.2. Market Revenue and Volume Forecast, by Application
13.3.6.3. Market Revenue and Volume Forecast, by End-Use Industry
13.3.6.4. Market Revenue and Volume Forecast, by Form
13.3.7. Market Revenue and Volume Forecast, by Production Method
13.3.8. China
13.3.8.1. Market Revenue and Volume Forecast, by Type
13.3.8.2. Market Revenue and Volume Forecast, by Application
13.3.8.3. Market Revenue and Volume Forecast, by End-Use Industry
13.3.8.4. Market Revenue and Volume Forecast, by Form
13.3.9. Market Revenue and Volume Forecast, by Production Method
13.3.10. Japan
13.3.10.1. Market Revenue and Volume Forecast, by Type
13.3.10.2. Market Revenue and Volume Forecast, by Application
13.3.10.3. Market Revenue and Volume Forecast, by End-Use Industry
13.3.10.4. Market Revenue and Volume Forecast, by Form
13.3.10.5. Market Revenue and Volume Forecast, by Production Method
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Volume Forecast, by Type
13.3.11.2. Market Revenue and Volume Forecast, by Application
13.3.11.3. Market Revenue and Volume Forecast, by End-Use Industry
13.3.11.4. Market Revenue and Volume Forecast, by Form
13.3.11.5. Market Revenue and Volume Forecast, by Production Method
13.4. MEA
13.4.1. Market Revenue and Volume Forecast, by Type
13.4.2. Market Revenue and Volume Forecast, by Application
13.4.3. Market Revenue and Volume Forecast, by End-Use Industry
13.4.4. Market Revenue and Volume Forecast, by Form
13.4.5. Market Revenue and Volume Forecast, by Production Method
13.4.6. GCC
13.4.6.1. Market Revenue and Volume Forecast, by Type
13.4.6.2. Market Revenue and Volume Forecast, by Application
13.4.6.3. Market Revenue and Volume Forecast, by End-Use Industry
13.4.6.4. Market Revenue and Volume Forecast, by Form
13.4.7. Market Revenue and Volume Forecast, by Production Method
13.4.8. North Africa
13.4.8.1. Market Revenue and Volume Forecast, by Type
13.4.8.2. Market Revenue and Volume Forecast, by Application
13.4.8.3. Market Revenue and Volume Forecast, by End-Use Industry
13.4.8.4. Market Revenue and Volume Forecast, by Form
13.4.9. Market Revenue and Volume Forecast, by Production Method
13.4.10. South Africa
13.4.10.1. Market Revenue and Volume Forecast, by Type
13.4.10.2. Market Revenue and Volume Forecast, by Application
13.4.10.3. Market Revenue and Volume Forecast, by End-Use Industry
13.4.10.4. Market Revenue and Volume Forecast, by Form
13.4.10.5. Market Revenue and Volume Forecast, by Production Method
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Volume Forecast, by Type
13.4.11.2. Market Revenue and Volume Forecast, by Application
13.4.11.3. Market Revenue and Volume Forecast, by End-Use Industry
13.4.11.4. Market Revenue and Volume Forecast, by Form
13.4.11.5. Market Revenue and Volume Forecast, by Production Method
13.5. Latin America
13.5.1. Market Revenue and Volume Forecast, by Type
13.5.2. Market Revenue and Volume Forecast, by Application
13.5.3. Market Revenue and Volume Forecast, by End-Use Industry
13.5.4. Market Revenue and Volume Forecast, by Form
13.5.5. Market Revenue and Volume Forecast, by Production Method
13.5.6. Brazil
13.5.6.1. Market Revenue and Volume Forecast, by Type
13.5.6.2. Market Revenue and Volume Forecast, by Application
13.5.6.3. Market Revenue and Volume Forecast, by End-Use Industry
13.5.6.4. Market Revenue and Volume Forecast, by Form
13.5.7. Market Revenue and Volume Forecast, by Production Method
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Volume Forecast, by Type
13.5.8.2. Market Revenue and Volume Forecast, by Application
13.5.8.3. Market Revenue and Volume Forecast, by End-Use Industry
13.5.8.4. Market Revenue and Volume Forecast, by Form
13.5.8.5. Market Revenue and Volume Forecast, by Production Method
14.1. Novozymes A/S
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. DSM N.V.
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Amano Enzyme Inc.
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Takeda Pharmaceutical Company Limited
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Meiji Seika Pharma Co., Ltd.
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Codexis, Inc.
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Chr. Hansen Holding A/S
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Gist-Brocades (now part of DSM)
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Henan Lingrui Biochemical Co., Ltd.
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Advanced Enzymes Technologies Ltd.
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
16.1. About Us
16.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client